Immunosenescence in the older kidney transplant recipient; quantification, impact on clinical outcome, effect of immunosuppression and implementation
Targeting the CDA/P2Y6 axis to overcome immunosuppression and favor response to immune checkpoint inhibitors in pancreatic cancer
Liver Immunosuppression Free Trial (LIFT): Outcomes of the First Biomarker-Guided Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
Immune responses against islet allografts during tapering of immunosuppression - a pilot study in 5 subjects